Patent details

EP4065119 Title: INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION

Basic Information

Publication number:
EP4065119
PCT Application Number:
EP2020083593
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208200543
PCT Publication Number:
WO2021105331
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
French Title of Invention:
TRAITEMENT INITIAL PAR TRIPLE COMBINAISON AVEC MACITENTAN, TADALAFIL ET SELEXIPAG POUR TRAITER L'HYPERTENSION ARTÉRIELLE PULMONAIRE
German Title of Invention:
ANFÄNGLICHE DREIFACHKOMBINATIONSTHERAPIE MIT MACITENTAN, TADALAFIL UND SELEXIPAG ZUR BEHANDLUNG VON PULMONALER ARTERIELLER HYPERTENSION
SPC Number:

Dates

Filing date:
27/11/2020
Grant date:
04/09/2024
EP Publication Date:
05/10/2022
PCT Publication Date:
03/06/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2024
EP B1 Publication Date:
04/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/11/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/08/2024
 
 

Name:
Actelion Pharmaceuticals Ltd
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Inventor

1

Name:
PERCHENET, Loïc
Address:
Switzerland (CH)

2

Name:
MARESTA, Alessandro
Address:
Switzerland (CH)

Priority

1

Priority Number:
201962941910 P
Priority Date:
29/11/2019
Priority Country:
United States (US)

2

Priority Number:
202063023452 P
Priority Date:
12/05/2020
Priority Country:
United States (US)

3

Priority Number:
202063076149 P
Priority Date:
09/09/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4965; A61K 31/4985; A61K 31/505; A61K 31/506; A61K 31/519; A61K 31/53; A61P 9/12; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202436
Publication date:
04/09/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages